Concepedia

U. Kulsoom Abdul

UK

Statistics

Publications

3

Citations

175

H-Index

3

Active since

2017

Affiliations

University of Lausanne(Current)

U. Kulsoom Abdul is an author at University of Lausanne specializing in egfr inhibition, molecular oncology, and epidermal growth factor receptor inhibition.

Publications per year

2017–2022

3

Publications

3

Combination of ruthenium(II)-arene complex [Ru(η6-p-cymene)Cl2(pta)] (RAPTA-C) and the epidermal growth factor receptor inhibitor erlotinib results in efficient angiostatic and antitumor activity

Robert H. Berndsen, Andrea Weiss, U. Kulsoom Abdul et al. · Scientific Reports · 2017 · 107 citations · Full text

, , +13

The TICking clock of EGFR therapy resistance in glioblastoma: Target Independence or target Compensation

Hamza Saleem, U. Kulsoom Abdul, Megan Houweling et al. · Drug Resistance Updates · 2019 · 49 citations · Full text

, , +16

Radio-sensitizing effect of MEK inhibition in glioblastoma in vitro and in vivo

Megan Houweling, U. Kulsoom Abdul, Cyrillo G. Brahm et al. · Journal of Cancer Research and Clinical Oncology · 2022 · 19 citations · Full text

, , +13

1–3 of 3